Organogenesis Holdings Inc. (ORGO)
ORGONASDAQ-CMBiotechnology: Pharmaceutical Preparations
$0.9352
+0.0518 (+5.86%) today
Closed, Nov 10, 4:00 PM ET
- Market cap
- $121.39m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.7300 to $7.08
- Average volume
- 845.3k
- Previous close
- $0.8834
Analysts
2 coveringHold0 buy, 2 hold, 0 sell
Targets a year out average $2.00, +113.9% from here
Earnings
Next report
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $150.86m | $225.61m | $37.23m | $43.76m |
| Gross profit | $114.61m | $175.69m | $11.46m | $20.08m |
| Operating income | $20.73m | $63.29m | -$68.89m | -$50.99m |
| Net income | $21.57m | $43.70m | -$53.16m | -$96.27m |
Last four quarters: revenue $457.45m, margin -18.4%, free cash flow $20.84m
News
8 latest- Organogenesis: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 5 days ago
- Organogenesis (ORGO) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Organogenesis Q3 Earnings Call HighlightsMarketBeat · 5 days ago
- Organogenesis (ORGO) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 13, 2026
- Organogenesis Q2 Earnings Call HighlightsMarketBeat · Aug 7, 2026
- Organogenesis Publishes Positive RCT Data For Affinity Graft In Treating Venous Leg Ulcers RTTNews · Jul 28, 2026
- Organogenesis Secures FDA Review For ReNu In Knee Osteoarthritis RTTNews · Jul 7, 2026
- Truist Securities Initiates Coverage of Organogenesis Holdings (ORGO) with Hold RecommendationFintel · May 28, 2026
The company
Organogenesis Holdings Inc. is a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacture, and sale of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- organogenesis.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.